FIELD: medicine.
SUBSTANCE: method of the invention comprises administration of 4,4'-[fluoro(1H-1,2,4-triazol-1-yl)methylene]bisbenzonitrile to a male patient with the total serum testosterone level of less than 400 ng/dl, at a dose of 0.001-1.0 mg weekly. The composition of the invention includes a pharmaceutical composition and instructions for administration.
EFFECT: increased testosterone levels in these patients.
19 cl, 2 tbl, 5 ex
Authors
Dates
2017-08-22—Published
2012-09-06—Filed